Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07146061 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

pCAD-POAF 3 Year Follow-up

StatusRecruiting
PhaseNot specified
Started2025-08-15
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from China National Center for Cardiovascular Diseases

Amendment history

2026-10-02
Recruitment opened
Primary endpoint(s) modified1 entry, revised
WasAF burden
NowA composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation.
This study will include the subjects who enrolled in pCAD-POAF trial (NCT05009914) to observe clinical outcomes 3 years after surgery. The primary outcome is the time to first occurrence of a composite of all-cause death, stroke, systemic embolism, myocardial infarction, unplanned cardiac rehospitalization, or post-discharge atrial fibrillation from randomization through 3 years after surgery. The secondary outcomes are：the individual components of the primary composite outcome; unplanned all-cause rehospitalization; arrhythmias other than atrial fibrillation; premature atrial contraction and premature ventricular contraction burdens; heart rate variability parameters; quality-of-life scores; and other Holter-derived parameters.
Trial Details
NCT Number NCT07146061
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Coronary Artery Disease, Atrial Fibrillation
Enrollment 430 participants
Start Date 2025-08-15
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-10-01